Reducing the number of unplanned returns to hospital after treatment for peripheral artery disease

Bethany Stavert and Sarah Aitken
Med J Aust 2022; 216 (2): . || doi: 10.5694/mja2.51369
Published online: 7 February 2022

Improved, integrated care for older patients with complex medical needs could avert some modifiable causes of readmission

The incidence of peripheral artery disease (PAD) is rising around the world as populations age and the prevalence of diabetes, obesity, and cardiovascular disease increase.1 The clinical manifestations of lower limb PAD range from asymptomatic atherosclerosis and exertional pain caused by intermittent claudication, to chronic limb‐threatening ischaemia with rest pain, ulceration, and necrosis. Long term survival is poorer for patients with PAD than for people with many common cancers,1 and quality of life and patient‐reported outcomes are impaired.2 A recently published analysis of Global Burden of Disease Study data found that lower limb amputation rates were higher in Australia than in eighteen other high income countries, highlighting the need to improve outcomes for people with PAD.3

  • 1 Concord Institute of Academic Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia
  • 2 Concord Clinical School, University of Sydney, Sydney, NSW, Australia


Competing interests:

No relevant disclosures.

  • 1. Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382: 1329–1340.
  • 2. Abaraogu UO, Ezenwankwo EF, Dall PM, Seenan CA. Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease. PLoS One 2018; 13: e0207456.
  • 3. Hughes W, Goodall R, Salciccioli JD, et al. Trends in lower extremity amputation incidence in European Union 15+ countries 1990–2017. Eur J Vasc Endovasc Surg 2020; 60: 602–612.
  • 4. Woelk V, Speck P, Kaambwa B, et al. Incidence and causes of early unplanned readmission after hospitalisation with peripheral arterial disease in Australia and New Zealand. Med J Aust 2022; 216: 80–86.
  • 5. Smith SL, Matthews EO, Moxon JV, Golledge J. A systematic review and meta‐analysis of risk factors for and incidence of 30‐day readmission after revascularization for peripheral artery disease. J Vasc Surg 2019; 70: 996–1006.e7.
  • 6. Thillainadesan J, Aitken SJ, Monaro SR, et al. Geriatric comanagement of older vascular surgery inpatients reduces hospital‐acquired geriatric syndromes. J Am Med Dir Assoc 2021; [online ahead of print].
  • 7. Thillainadesan J, Yumol MF, Hilmer S, et al. Interventions to improve clinical outcomes in older adults admitted to a surgical service: a systematic review and meta‐analysis. J Am Med Dir Assoc 2020; 21: 1833–1843.
  • 8. Vogel TR, Kruse RL. Risk factors for readmission after lower extremity procedures for peripheral artery disease. J Vasc Surg 2013; 58: 90–97.e1‐4.
  • 9. Anand SS, Caron F, Eikelboom JW, et al. Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial. J Am Coll Cardiol 2018; 71: 2306–2315.
  • 10. Paige E, Doyle K, Jorm L, et al. A versatile big data health system for Australia: driving improvements in cardiovascular health. Heart Lung Circ 2021; 30: 1467–1476.
  • 11. Medicare Benefits Schedule Review Taskforce. Vascular Clinical Committee report. Updated 28 May 2021.‐findings‐vascular‐clinical‐committee‐report (viewed Dec 2021).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.